poisar

Stock

OmniAb, Inc. OABI

$3.43+0.29%

Overview

OABI market data

Price History

OABI price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.57
Diluted earnings per share over the trailing twelve months.
Beta
0.57
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-187.6%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.30 – $3.55
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $492.9M · P/B 1.00 · P/S 17.03.

Company News

9 captured
Natera, Doximity, PubMatic, Airbnb And Other Big Stocks Moving Higher On FridayBenzinga · Aug 7, 2026, 7:35 PM
12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · Aug 7, 2026, 5:05 PM
OmniAb shares are trading higher after the company reported better-than-expected Q2 financial results. The company also raised its FY2026 sales guidance above estimates.Benzinga · Aug 7, 2026, 3:33 PM
OmniAb Raises FY2026 Sales Guidance from $28.000M-$33.000M to $32.000M-$36.000M vs $30.807M EstBenzinga · Aug 6, 2026, 8:24 PM
OmniAb Q2 EPS $(0.05) Beats $(0.12) Estimate, Sales $13.415M Beat $4.693M EstimateBenzinga · Aug 6, 2026, 8:09 PM
VERAXA Biotech Advances Bispecific ADC VXA‑222 With OmniAb Milestone, Moving Alliance Into Next Phase Of Cancer Therapy DiscoveryBenzinga · Jul 27, 2026, 11:07 AM
8-K filing — OmniAb, Inc. (OABI)SEC EDGAR · Jul 13, 2026, 12:06 PM
OmniAb Names Amechi Nwachuku To Newly-Created Position Of Executive Vice President And COOBenzinga · Jul 13, 2026, 12:05 PM
VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development TimelinesGlobenewswire Inc · Jul 6, 2026, 11:15 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock